[go: up one dir, main page]

HK40090038A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation Download PDF

Info

Publication number
HK40090038A
HK40090038A HK62023078876.7A HK62023078876A HK40090038A HK 40090038 A HK40090038 A HK 40090038A HK 62023078876 A HK62023078876 A HK 62023078876A HK 40090038 A HK40090038 A HK 40090038A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
HK62023078876.7A
Other languages
Chinese (zh)
Inventor
Twinkle R. CHRISTIAN
Bharadwaj JAGANNATHAN
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of HK40090038A publication Critical patent/HK40090038A/en

Links

HK62023078876.7A 2020-04-29 2021-04-28 Pharmaceutical formulation HK40090038A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/017,061 2020-04-29

Publications (1)

Publication Number Publication Date
HK40090038A true HK40090038A (en) 2023-10-27

Family

ID=

Similar Documents

Publication Publication Date Title
AU2021399009A9 (en) Isocycloseram formulation
EP4216937A4 (en) Extended release pharmaceutical formulation
GB202010230D0 (en) Pharmaceutical formulation
EP4190310A4 (en) Stable pharmaceutical preparation
GB202100526D0 (en) Pharmaceutical formulation
IL297081A (en) Pharmaceutical formulation
IL297080A (en) Pharmaceutical formulation
EP4205765A4 (en) Stable pharmaceutical preparation
HK40103575A (en) Pharmaceutical formulation
HK40097541A (en) Pharmaceutical formulation
HK40090037A (en) Pharmaceutical formulation
HK40090038A (en) Pharmaceutical formulation
HK40113753A (en) Pharmaceutical formulation
HK40100860A (en) Pharmaceutical formulations
HK40091202A (en) Pharmaceutical formulations
HK40089663A (en) Pharmaceutical formulations
HK40085410A (en) Pharmaceutical formulations
HK40080656A (en) Pharmaceutical formulations
AU2020903780A0 (en) Pharmaceutical formulations
AU2020903781A0 (en) Pharmaceutical formulations
HK40118631A (en) New pharmaceutical formulation
HK40106463A (en) Pharmaceutical composition comprising p-boronophenylalanine
HK40105586A (en) Pharmaceutical composition comprising enavogliflozin
HK40088923A (en) Extended release pharmaceutical formulation
HK40088924A (en) Extended release pharmaceutical formulation